Janus Henderson Group PLC Has $15.14 Million Holdings in Simulations Plus, Inc. (NASDAQ:SLP)

Janus Henderson Group PLC increased its stake in shares of Simulations Plus, Inc. (NASDAQ:SLP) by 7,753.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 542,899 shares of the technology company’s stock after purchasing an additional 535,986 shares during the period. Janus Henderson Group PLC owned approximately 2.70% of Simulations Plus worth $15,141,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the stock. Proficio Capital Partners LLC bought a new position in Simulations Plus during the fourth quarter worth about $719,000. JPMorgan Chase & Co. lifted its holdings in Simulations Plus by 106.0% during the third quarter. JPMorgan Chase & Co. now owns 47,365 shares of the technology company’s stock worth $1,517,000 after acquiring an additional 24,371 shares in the last quarter. Sei Investments Co. bought a new position in Simulations Plus during the fourth quarter worth about $330,000. Tributary Capital Management LLC lifted its holdings in Simulations Plus by 21.7% during the fourth quarter. Tributary Capital Management LLC now owns 396,093 shares of the technology company’s stock worth $11,047,000 after acquiring an additional 70,526 shares in the last quarter. Finally, AlphaQuest LLC lifted its holdings in Simulations Plus by 502.9% during the fourth quarter. AlphaQuest LLC now owns 2,689 shares of the technology company’s stock worth $75,000 after acquiring an additional 2,243 shares in the last quarter. 78.08% of the stock is owned by institutional investors and hedge funds.

Simulations Plus Price Performance

Shares of Simulations Plus stock opened at $31.53 on Friday. Simulations Plus, Inc. has a one year low of $23.01 and a one year high of $50.98. The firm has a market cap of $634.10 million, a price-to-earnings ratio of 78.83 and a beta of 1.10. The stock’s 50-day moving average is $29.06 and its 200-day moving average is $30.25.

Simulations Plus (NASDAQ:SLP) last released its earnings results on Thursday, April 3rd. The technology company reported $0.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.25 by $0.06. Simulations Plus had a return on equity of 6.84% and a net margin of 10.97%. The business had revenue of $22.43 million for the quarter, compared to analyst estimates of $21.93 million. During the same quarter in the prior year, the company posted $0.20 earnings per share. Simulations Plus’s revenue was up 22.5% on a year-over-year basis. On average, equities analysts expect that Simulations Plus, Inc. will post 1.09 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the company. KeyCorp lifted their target price on Simulations Plus from $32.00 to $40.00 and gave the stock an “overweight” rating in a report on Wednesday, April 16th. StockNews.com upgraded Simulations Plus from a “sell” rating to a “hold” rating in a report on Monday, April 28th. Two equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $50.00.

Insider Buying and Selling

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the company’s stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $33.51, for a total value of $670,200.00. Following the sale, the director now owns 3,344,157 shares in the company, valued at $112,062,701.07. This represents a 0.59% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 19.40% of the stock is currently owned by corporate insiders.

Simulations Plus Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.